BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25736011)

  • 1. Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activated.
    Fisher RI; Khan N
    J Natl Compr Canc Netw; 2015 Mar; 13(3):363-6. PubMed ID: 25736011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is observation dead in follicular lymphoma? Still appropriate.
    Jacobson CA; Freedman AS
    J Natl Compr Canc Netw; 2015 Mar; 13(3):367-70. PubMed ID: 25736012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
    Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
    Cohen JB; Kahl BS
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of follicular lymphoma.
    Hitz F; Ketterer N; Lohri A; Mey U; Pederiva S; Renner C; Taverna C; Hartmann A; Yeow K; Bodis S; Zucca E
    Swiss Med Wkly; 2011; 141():w13247. PubMed ID: 21815111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
    Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008909. PubMed ID: 23832787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular lymphoma: current management and future directions.
    Bello C; Zhang L; Naghashpour M
    Cancer Control; 2012 Jul; 19(3):187-95. PubMed ID: 22710894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management strategy for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open questions in watchful waiting for follicular lymphoma.
    Sorigue M; Sancho JM; Ribera JM
    Br J Haematol; 2017 Nov; 179(4):679-681. PubMed ID: 27390920
    [No Abstract]   [Full Text] [Related]  

  • 11. Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.
    Reagan PM; Friedberg JW
    Curr Treat Options Oncol; 2015 Jul; 16(7):32. PubMed ID: 26031546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low grade lymphoma: research progress and questions about treatment].
    Ishizawa K
    Rinsho Ketsueki; 2015 Oct; 56(10):2039-46. PubMed ID: 26458443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Follicular lymphoma].
    Tomita N
    Nihon Rinsho; 2014 Mar; 72(3):488-92. PubMed ID: 24724409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.
    Nozaki K; Sugahara H; Ueda S; Ishikawa J; Karasuno T; Iida M; Kamae T; Moriyama Y; Kawakami M; Kosugi S; Nakagawa M; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
    Int J Hematol; 2021 Aug; 114(2):217-221. PubMed ID: 33847924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
    Găman AM
    Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
    Tari A; Asaoku H; Takata K; Fujimori S; Tanaka S; Fujihara M; Koga T; Yoshino T
    Scand J Gastroenterol; 2016 Mar; 51(3):321-8. PubMed ID: 26382560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective study on the management of patients with rituximab refractory follicular lymphoma.
    Solal-Céligny P; Leconte P; Bardet A; Hernandez J; Troussard X
    Br J Haematol; 2018 Jan; 180(2):217-223. PubMed ID: 29230799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for "watch and wait" in follicular lymphoma in the rituximab era?
    Kahl B
    Hematology Am Soc Hematol Educ Program; 2012; 2012():433-8. PubMed ID: 23233615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL).
    Rusconi C; Anastasia A; Chiarenza A; Marcheselli L; Cavallo F; Rattotti S; Botto B; Ferrari A; Nassi L; Pagani C; Meli E; Arcaini L; Federico M; Rossi G;
    Br J Haematol; 2019 May; 185(4):713-717. PubMed ID: 30793297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.